Digestive system disorders: gastroesophageal reflux disease.
This article comes from Clinical Evidence (1999; 1 : 145-153), a new resource for clinicians produced jointly by the BMJ Publishing Group and the American College of Physicians-American Society of Internal Medicine. Clinical Evidence is an extensively peer-reviewed publication that summarizes the best available evidence on the effects of common clinical interventions gleaned from thorough searches and appraisal of the world literature. It became available in the United States late last year. Please see advertisement for more information or, alternatively, visit the web site at www. evidence.org.
Katzka
D A
DA
Gastroenterology Division, University of Pennsylvania Health System, Philadelphia 19104-4283, USA. katzka@mail.med.upenn.edu
D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018662:Fundoplication; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D016623:Ion Pumps / Q000037:antagonists & inhibitors; D010535:Laparoscopy; D055502:Secondary Prevention; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D006635:Histamine H2 Antagonists; D016623:Ion Pumps